University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance

Phase 2

Recruiting

Conditions: Prostate Adenocarcinoma
Prostate Cancer

Interventions: Drug: Hyperpolarized Carbon C 13 Pyruvate
Procedure: Magnetic Resonance Spectroscopic Imaging
Procedure: MRI Ultrasound Fusion Guided Biopsy

First Posted Date: 2019-05-01

Last Posted Date: 2024-02-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT03933670

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Acute Pain Management in Patients on Opioid Replacement Therapy

Phase 1

Terminated

Conditions: Pain, Acute
Opioid-use Disorder

Interventions: Drug: HYDROmorphone Injectable Solution
Drug: Ketamine
Drug: Placebos

First Posted Date: 2019-05-01

Last Posted Date: 2022-10-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1

Registration Number: NCT03933865

Locations: 🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States

Rapid Detection of Airway Pathogens for Lung Transplantation

Completed

Conditions: Pulmonary Infection
Lung Transplantation
Respiratory Tract Infections

First Posted Date: 2019-05-01

Last Posted Date: 2021-03-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 200

Registration Number: NCT03933878

Locations: 🇺🇸
UCSF Parnassus, San Francisco, California, United States

Consequences of Unwanted Pregnancy in Nepal

Active, not recruiting

Conditions: Unwanted Pregnancy

Interventions: Other: Receipt of termination services outside of legal setting

First Posted Date: 2019-04-29

Last Posted Date: 2024-06-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1436

Registration Number: NCT03930576

Locations: 🇳🇵
CREHPA, Kathmandu, Nepal

A Feasibility Study Evaluating a Novel Mask (Nasal Reservoir Cannula)

Not Applicable

Terminated

Conditions: Pneumonia Childhood

Interventions: Device: Nasal reservoir cannula

First Posted Date: 2019-04-26

Last Posted Date: 2019-04-26

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 8

Registration Number: NCT03929484

Locations: 🇺🇬
Mulago Hospital, Kampala, Uganda

Mobile Technology to Extend Clinic-based Counseling for HIV+s in Uganda

Not Applicable

Completed

Conditions: Alcohol Use, Unspecified
HIV/AIDS

Interventions: Behavioral: In-person counseling session
Behavioral: Technology (IVR or SMS) booster session
Behavioral: Live phone call booster session

First Posted Date: 2019-04-26

Last Posted Date: 2023-09-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 272

Registration Number: NCT03928418

Locations: 🇺🇬
Mbarara University of Science and Technology/Mbarara Regional Referral Hospital, Mbarara, Uganda

Pragmatic Research of Acupuncture and Counseling eXtended to Inpatient Services

Not Applicable

Completed

Conditions: Pain
Malignant Solid Tumor

Interventions: Procedure: Acupuncture
Behavioral: Pain Counseling

First Posted Date: 2019-04-05

Last Posted Date: 2021-10-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 448

Registration Number: NCT03905720

Locations: 🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

Mindfulness-based Cognitive Therapy (MBCT) for People With Parkinson's Disease

Not Applicable

Completed

Conditions: Depression
Anxiety
Parkinson Disease

Interventions: Behavioral: Mindfulness-based cognitive therapy (MBCT)

First Posted Date: 2019-04-05

Last Posted Date: 2020-05-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 16

Registration Number: NCT03904654

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Pilot Human Lab Study of Lacosamide in Alcohol Use Disorder (AUD)

Phase 2

Completed

Conditions: Alcohol Use Disorder

Interventions: Drug: Placebo
Drug: Lacosamide 100 mg
Drug: Lacosamide 200 mg

First Posted Date: 2019-04-01

Last Posted Date: 2022-06-28

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 4

Registration Number: NCT03897348

Locations: 🇺🇸
San Francisco VA Health Care System, San Francisco, California, United States

Pilot Human Laboratory Study of Alcohol Approach Bias Modification (AABM) for Alcohol Use Disorder (AUD)

Not Applicable

Completed

Conditions: Alcohol Use Disorder

Interventions: Device: Alcohol Approach Bias Modification

First Posted Date: 2019-04-01

Last Posted Date: 2024-06-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 3

Registration Number: NCT03898323

Locations: 🇺🇸
San Francisco VA Health Care System, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy